LMNA and cardiomyopathy: Two recent studies demonstrated that Lmna H222P/H222P as well as Lmna−/− and Lmna+/− embryonic hearts exhibit noncompaction, suggesting these mouse models as important tools to study the developmental origin and the mechanisms behind LMNA-mediated noncompaction cardiomyopathy [63,75].